In an editorial this weekend, the New York Times supported efforts by the Petrie-Flom Center and suggested it was time for Congress to consider lifting the effective ban on mitochondrial replacement therapies.
By David Orentlicher [Cross-posted at Health Law Profs blog] As NPR reported this morning, researchers in England may soon use genetic therapy to treat diseases that result from defects in mitochondrial DNA. Mitochondria create energy for cells, and they have their own genes, distinct from the genes that help determine our looks, behavior, and other…
